Kuwait vs South-East Asia (WHO region): Treatment success rate for patients treated for MDR-TB

Kuwait
100.0%
in 2021
South-East Asia (WHO region)
77.0%
in 2022
Kuwait rank
1st
South-East Asia (WHO region) rank
2nd

Treatment success rate for patients treated for MDR-TB over time

  • Kuwait
  • South-East Asia (WHO region)
20406080100200220122022

How they compare

Kuwait currently reports 100.0% against 77.0% in South-East Asia (WHO region), a difference of 23.0%.

That makes Kuwait's figure about 1.3 times South-East Asia (WHO region)'s.

The two have swapped places 6 times across 14 shared years of data; in 2006 it was Kuwait ahead.

Kuwait ranks 1st and South-East Asia (WHO region) ranks 2nd of 163 countries.

Across the 3 decades both report, Kuwait averaged higher in 2 and South-East Asia (WHO region) in 1.

Head to head by decade

Decade Kuwait South-East Asia (WHO region) Difference Ahead
2000s 45.0% 62.7% 17.7% South-East Asia (WHO region)
2010s 73.1% 52.7% 20.4% Kuwait
2020s 100.0% 71.0% 29.0% Kuwait

Averages of every year both report within each decade.

Frequently asked questions

Which has higher treatment success rate for patients treated for mdr-tb, Kuwait or South-East Asia (WHO region)?
Kuwait, at 100.0% against 77.0% in South-East Asia (WHO region) as of 2021.
What is the difference in treatment success rate for patients treated for mdr-tb between Kuwait and South-East Asia (WHO region)?
23.0%, with Kuwait ahead.
How many years of comparable data are there for Kuwait and South-East Asia (WHO region)?
14 years are reported by both, from 2006 to 2021.
How do Kuwait and South-East Asia (WHO region) rank globally for treatment success rate for patients treated for mdr-tb?
Kuwait ranks 1st and South-East Asia (WHO region) ranks 2nd of 163 countries.
Where does this data come from?
World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Kuwait vs South-East Asia (WHO region): Treatment success rate for patients treated for MDR-TB. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 17 September 2026, from https://health.statizoid.com/compare/treatment-success-rate-for-patients-treated-for-mdr-tb-percent/kuwait/south-east-asia-who-region/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/treatment-success-rate-for-patients-treated-for-mdr-tb-percent/kuwait/south-east-asia-who-region/">Kuwait vs South-East Asia (WHO region): Treatment success rate for patients treated for MDR-TB</a> — Statizoid

About this data

Indicator
Treatment success rate for patients treated for MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
175 places, 2,495 data points, 1999–2022
Last refreshed